|
||
J. Exp. Med.,
Volume 187, Number 11, June 1, 1998 1871-1883
By



From the * Laboratoire de Biologie Moléculaire du Gène, Institut National de la Santé et de la
Recherche Médicale U277 and Institut Pasteur, 75724 Paris, France; the The positive selection of CD4+ T cells requires the expression of major histocompatibility
complex (MHC) class II molecules in the thymus, but the role of self-peptides complexed to
class II molecules is still a matter of debate. Recently, it was observed that transgenic mice expressing a single peptide-MHC class II complex positively select significant numbers of diverse
CD4+ T cells in the thymus. However, the number of selected T cell specificities has not been
evaluated so far. Here, we have sequenced 700 junctional complementarity determining regions 3 (CDR3) from T cell receptors (TCRs) carrying V
Department of Genetics,
Medical Institute of Bioregulation and Ministry of Education, Science, Sports and Culture, Japan
Science and Technology Corporation, Fukuoka 812, Japan; and the § Information Genetique et
Structurale, Centre National de la Recherche Scientifique, Institut de Biologie Structurale et
Microbiologie, 13402 Marseille, France
11-J
1.1 or V
12-J
1.1 rearrangements. We found that a single peptide-MHC class II complex positively selects at least 105 different V
rearrangements. Our data yield a first evaluation of the size of the T cell repertoire.
In addition, they provide evidence that the single E
52-68-I-Ab complex skews the amino
acid frequency in the TCR CDR3 loop of positively selected T cells. A detailed analysis of
CDR3 sequences indicates that a fraction of the
chain repertoire bears the imprint of the selecting self-peptide.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|